View in EDS HTML Full Text PDF Full Text

Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.

Saved in:
Bibliographic Details
Title: Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
Authors: Kopp RM; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. francesco.massari@aosp.bo.it.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. francesco.massari@aosp.bo.it., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Schieber TJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Kansas city, USA., Ürün Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Türkiye; Westwood, Ankara, KS, 06620, USA., Kopecký J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Basso U; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Büttner T; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany., Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Myint ZW; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Galli L; Oncology Unit 2, University Hospital of Pisa, 56126, Pisa, Italy., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic., Rizzo M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari, Bari, Italy., Bolek H; Department of Medical Oncology, Faculty of Medicine, Ankara University, Türkiye; Westwood, Ankara, KS, 06620, USA., Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Conteduca V; Unit of Medical Oncology and Biomolecular Therapy and C.R.E.A, T.E - Center for Research and Innovation Medicine, Department. of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy., Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain., Rizzo A; S.S.D. C.O.R.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori ''Giovanni Paolo II'', Viale Orazio Flacco 65, 70124, Bari, Italy., Rosellini M; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Zgura A; Department of Oncology-Radiotherapy, Alexandru Trestioreanu Institute of Oncology, ''Carol Davila'' University of Medicine and Pharmacy, 020021, Bucharest, Romania., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy., Partl A; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Yildirim A; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA., Akova U; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Monteiro FSM; Oncology and Hematology Department, Hospital Sírio Libanês, Brasília, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology Unit, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Porta C; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari, Bari, Italy.; Interdisciplinary Department of Medicine, University of Bari ''Aldo Moro'', Bari, Italy., Bilen MA; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Li H; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Kansas city, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Nov 14; Vol. 74 (12), pp. 374. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41236632
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kopp+RM%22">Kopp RM</searchLink>; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia.<br /><searchLink fieldCode="AU" term="%22Massari+F%22">Massari F</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. francesco.massari@aosp.bo.it.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. francesco.massari@aosp.bo.it.<br /><searchLink fieldCode="AU" term="%22Grande+E%22">Grande E</searchLink>; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Schieber+TJ%22">Schieber TJ</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Kansas city, USA.<br /><searchLink fieldCode="AU" term="%22Ürün+Y%22">Ürün Y</searchLink>; Department of Medical Oncology, Faculty of Medicine, Ankara University, Türkiye; Westwood, Ankara, KS, 06620, USA.<br /><searchLink fieldCode="AU" term="%22Kopecký+J%22">Kopecký J</searchLink>; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia.<br /><searchLink fieldCode="AU" term="%22Molina-Cerrillo+J%22">Molina-Cerrillo J</searchLink>; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Basso+U%22">Basso U</searchLink>; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Kucharz+J%22">Kucharz J</searchLink>; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Büttner+T%22">Büttner T</searchLink>; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Pichler+R%22">Pichler R</searchLink>; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Fiala+O%22">Fiala O</searchLink>; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Myint+ZW%22">Myint ZW</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.<br /><searchLink fieldCode="AU" term="%22Galli+L%22">Galli L</searchLink>; Oncology Unit 2, University Hospital of Pisa, 56126, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Buchler+T%22">Buchler T</searchLink>; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Rizzo+M%22">Rizzo M</searchLink>; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Bolek+H%22">Bolek H</searchLink>; Department of Medical Oncology, Faculty of Medicine, Ankara University, Türkiye; Westwood, Ankara, KS, 06620, USA.<br /><searchLink fieldCode="AU" term="%22Bourlon+MT%22">Bourlon MT</searchLink>; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Conteduca+V%22">Conteduca V</searchLink>; Unit of Medical Oncology and Biomolecular Therapy and C.R.E.A, T.E - Center for Research and Innovation Medicine, Department. of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy.<br /><searchLink fieldCode="AU" term="%22Pinto+A%22">Pinto A</searchLink>; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rizzo+A%22">Rizzo A</searchLink>; S.S.D. C.O.R.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori ''Giovanni Paolo II'', Viale Orazio Flacco 65, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Rosellini+M%22">Rosellini M</searchLink>; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Roviello+G%22">Roviello G</searchLink>; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Zgura+A%22">Zgura A</searchLink>; Department of Oncology-Radiotherapy, Alexandru Trestioreanu Institute of Oncology, ''Carol Davila'' University of Medicine and Pharmacy, 020021, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Mollica+V%22">Mollica V</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Partl+A%22">Partl A</searchLink>; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Yildirim+A%22">Yildirim A</searchLink>; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Akova+U%22">Akova U</searchLink>; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Buti+S%22">Buti S</searchLink>; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Monteiro+FSM%22">Monteiro FSM</searchLink>; Oncology and Hematology Department, Hospital Sírio Libanês, Brasília, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Soares+A%22">Soares A</searchLink>; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology Unit, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Porta+C%22">Porta C</searchLink>; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico Di Bari, Bari, Italy.; Interdisciplinary Department of Medicine, University of Bari ''Aldo Moro'', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Bilen+MA%22">Bilen MA</searchLink>; Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Kansas city, USA.<br /><searchLink fieldCode="AU" term="%22Santoni+M%22">Santoni M</searchLink>; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 Nov 14; Vol. 74 (12), pp. 374. <i>Date of Electronic Publication: </i>2025 Nov 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41236632
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-025-04230-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 374
    Titles:
      – TitleFull: Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kopp RM
      – PersonEntity:
          Name:
            NameFull: Massari F
      – PersonEntity:
          Name:
            NameFull: Grande E
      – PersonEntity:
          Name:
            NameFull: Schieber TJ
      – PersonEntity:
          Name:
            NameFull: Ürün Y
      – PersonEntity:
          Name:
            NameFull: Kopecký J
      – PersonEntity:
          Name:
            NameFull: Molina-Cerrillo J
      – PersonEntity:
          Name:
            NameFull: Basso U
      – PersonEntity:
          Name:
            NameFull: Kucharz J
      – PersonEntity:
          Name:
            NameFull: Büttner T
      – PersonEntity:
          Name:
            NameFull: Pichler R
      – PersonEntity:
          Name:
            NameFull: Fiala O
      – PersonEntity:
          Name:
            NameFull: Myint ZW
      – PersonEntity:
          Name:
            NameFull: Galli L
      – PersonEntity:
          Name:
            NameFull: Buchler T
      – PersonEntity:
          Name:
            NameFull: Rizzo M
      – PersonEntity:
          Name:
            NameFull: Bolek H
      – PersonEntity:
          Name:
            NameFull: Bourlon MT
      – PersonEntity:
          Name:
            NameFull: Conteduca V
      – PersonEntity:
          Name:
            NameFull: Pinto A
      – PersonEntity:
          Name:
            NameFull: Rizzo A
      – PersonEntity:
          Name:
            NameFull: Rosellini M
      – PersonEntity:
          Name:
            NameFull: Roviello G
      – PersonEntity:
          Name:
            NameFull: Zgura A
      – PersonEntity:
          Name:
            NameFull: Mollica V
      – PersonEntity:
          Name:
            NameFull: Partl A
      – PersonEntity:
          Name:
            NameFull: Yildirim A
      – PersonEntity:
          Name:
            NameFull: Akova U
      – PersonEntity:
          Name:
            NameFull: Buti S
      – PersonEntity:
          Name:
            NameFull: Monteiro FSM
      – PersonEntity:
          Name:
            NameFull: Soares A
      – PersonEntity:
          Name:
            NameFull: Porta C
      – PersonEntity:
          Name:
            NameFull: Bilen MA
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Santoni M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2025 Nov 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1